1. Home
  2. MSAI vs CVKD Comparison

MSAI vs CVKD Comparison

Compare MSAI & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSAI
  • CVKD
  • Stock Information
  • Founded
  • MSAI 1995
  • CVKD 2022
  • Country
  • MSAI United States
  • CVKD United States
  • Employees
  • MSAI N/A
  • CVKD N/A
  • Industry
  • MSAI
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • MSAI
  • CVKD Health Care
  • Exchange
  • MSAI Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • MSAI 25.9M
  • CVKD 27.0M
  • IPO Year
  • MSAI N/A
  • CVKD 2023
  • Fundamental
  • Price
  • MSAI $1.34
  • CVKD $12.04
  • Analyst Decision
  • MSAI Strong Buy
  • CVKD Strong Buy
  • Analyst Count
  • MSAI 2
  • CVKD 1
  • Target Price
  • MSAI $2.75
  • CVKD $32.00
  • AVG Volume (30 Days)
  • MSAI 32.4M
  • CVKD 25.4K
  • Earning Date
  • MSAI 11-13-2025
  • CVKD 11-07-2025
  • Dividend Yield
  • MSAI N/A
  • CVKD N/A
  • EPS Growth
  • MSAI N/A
  • CVKD N/A
  • EPS
  • MSAI N/A
  • CVKD N/A
  • Revenue
  • MSAI $5,591,000.00
  • CVKD N/A
  • Revenue This Year
  • MSAI N/A
  • CVKD N/A
  • Revenue Next Year
  • MSAI $70.41
  • CVKD N/A
  • P/E Ratio
  • MSAI N/A
  • CVKD N/A
  • Revenue Growth
  • MSAI N/A
  • CVKD N/A
  • 52 Week Low
  • MSAI $0.46
  • CVKD $8.74
  • 52 Week High
  • MSAI $3.33
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • MSAI 58.44
  • CVKD 39.64
  • Support Level
  • MSAI $0.50
  • CVKD $12.71
  • Resistance Level
  • MSAI $2.40
  • CVKD $13.75
  • Average True Range (ATR)
  • MSAI 0.34
  • CVKD 0.84
  • MACD
  • MSAI 0.10
  • CVKD -0.11
  • Stochastic Oscillator
  • MSAI 44.21
  • CVKD 0.00

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: